AllianceBernstein
IBIO icon

AllianceBernstein’s iBio IBIO Stock Holding History

AllianceBernstein’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-273
Closed -$59K – 3317
2022
Q1 		$59K Buy
273
+1
+0.4% +$209 ﹤0.01% 3164
2021
Q4 		$75K Hold
272
– – ﹤0.01% 3220
2021
Q3 		$144K Hold
272
– – ﹤0.01% 3148
2021
Q2 		$205K Buy
272
+91
+50% +$66.4K ﹤0.01% 3150
2021
Q1 		$139K Hold
181
– – ﹤0.01% 3118
2020
Q4 		$95K Sell
181
-171
-49% -$139K ﹤0.01% 3108
2020
Q3 		$358K Hold
352
– – ﹤0.01% 2718
2020
Q2 		$391K Buy
+352
New +$230K ﹤0.01% 2755

Other funds holding IBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

AllianceBernstein's IBIO Position: Q2 2022 in Review

AllianceBernstein sold out of iBio (IBIO) in Q2 2022, closing a stake of 273 shares — an estimated $59K sold.

AllianceBernstein first reported a position in IBIO in Q2 2020 and held it in 8 quarters. The position peaked at $391K in Q2 2020. 53 funds tracked by Wall St. Rank hold IBIO as of Q2 2022.

  • AllianceBernstein reported no remaining iBio position as of Q2 2022 after selling out during the quarter.
  • AllianceBernstein sold 273 iBio shares in Q2 2022, an estimated $59K.
  • AllianceBernstein first reported a position in iBio in Q2 2020 and held it in 8 quarters.
  • AllianceBernstein's iBio position peaked at $391K in Q2 2020.
  • 53 funds tracked by Wall St. Rank held iBio as of Q2 2022.

Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.